SEC Form 4 · accession 0000899243-18-029911
SEELOS THERAPEUTICS, INC. · SEEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard W Pascoe
Officer — CEO & Secretary · Director
Period of report
Nov 30, 2018
Accepted (ET)
Nov 30, 2018 · 7:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001017491
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 30, 2018 | F | 17,290 | $0.306 | D | 200,206 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares forfeited by Reporting Person to cover certain tax liabilities incident to the vesting of the security.